PMID: 2106412Mar 1, 1990Paper

Long-term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy

Chest
E F ChristensenR Dahl

Abstract

Long-term treatment of chronic bronchitis with chest physiotherapy with or without positive expiratory pressure (PEP) by mask was studied in 43 patients randomly allocated to PEP treatment (PEP group, 20 patients) and conventional chest physiotherapy (control group, 23 patients). After instruction, the treatments were self-administered twice daily for 12 months (34 patients) and 5 months (9 patients). Twice weekly, patients filled in a diary concerning symptoms. The PEP group had significantly less cough and less mucus production. The number of acute exacerbations were calculated from the diaries and were lower in the PEP group compared to the control group, and 85 percent of the patients in the PEP group were free from acute exacerbations versus 48 percent in the control group. The PEP group also used less antibiotics and mucolytics. The PEP group had a small increase in FEV1 of mean 62 ml compared to a small decrease of 43 ml for the control group. Treatment with a simple PEP device can reduce morbidity in patients with chronic bronchitis and may preserve lung function from a more rapid decline.

Citations

Sep 26, 2002·Paediatric Respiratory Reviews·Cees P van der Schans
May 3, 2002·The New England Journal of Medicine·Alan F Barker
Dec 15, 2005·Journal of Palliative Medicine·Lauren B ElmanLeo McCluskey
Jan 1, 1995·Image--the Journal of Nursing Scholarship·M E Burman
Dec 12, 2007·BMC Pulmonary Medicine·Abdulaziz H AlzeerShaffi A Shaik
Nov 26, 2011·Respiration; International Review of Thoracic Diseases·D F Heigener, K F Rabe
Jun 24, 2004·Expert Opinion on Pharmacotherapy·Elizabeth Anne EdwardsCatherine Ann Byrnes
Dec 7, 2006·COPD·Markus O HenkeBruce K Rubin
Mar 29, 2007·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chien-Ling SuHorng-Chyuan Lin
Dec 13, 2005·Revue des maladies respiratoires·T Urban
Mar 20, 2004·Pediatric Pulmonology. Supplement·Marlyn S Woo
May 30, 2006·Chronic Respiratory Disease·Anne E Holland, Brenda M Button
Mar 16, 2012·The Cochrane Database of Systematic Reviews·Christian R OsadnikAnne E Holland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.